These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis. Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023 [TBL] [Abstract][Full Text] [Related]
27. Randomized comparison between intracoronary beta-radiation brachytherapy and implantation of paclitaxel-eluting stents for the treatment of diffuse in-stent restenosis. Schukro C; Syeda B; Kirisits C; Schmid R; Pichler P; Pokrajac B; Lang I; Pötter R; Glogar D Radiother Oncol; 2007 Jan; 82(1):18-23. PubMed ID: 16971011 [TBL] [Abstract][Full Text] [Related]
28. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Sarno G; Lagerqvist B; Fröbert O; Nilsson J; Olivecrona G; Omerovic E; Saleh N; Venetzanos D; James S Eur Heart J; 2012 Mar; 33(5):606-13. PubMed ID: 22232428 [TBL] [Abstract][Full Text] [Related]
29. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients. Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692 [TBL] [Abstract][Full Text] [Related]
30. Drug-eluting stents in bifurcation lesions: to stent one branch or both? Assali AR; Assa HV; Ben-Dor I; Teplitsky I; Solodky A; Brosh D; Fuchs S; Kornowski R Catheter Cardiovasc Interv; 2006 Dec; 68(6):891-6. PubMed ID: 17086532 [TBL] [Abstract][Full Text] [Related]
31. Immunosuppressive therapy with oral prednisone to prevent restenosis after PCI. A multicenter randomized trial. Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Abukaresh R; Aurigemma C; De Luca L; Zavalloni D; Soregaroli D; Marino P; Garbo R; Zanolla L; Vassanelli C; Am J Med; 2011 May; 124(5):434-43. PubMed ID: 21531233 [TBL] [Abstract][Full Text] [Related]
32. Drug-eluting coronary stents: many meta-analyses, little benefit. Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727 [TBL] [Abstract][Full Text] [Related]
33. Five-year clinical outcome after primary stenting of totally occluded native coronary arteries: a randomised comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions (PRISON II study). Van den Branden BJ; Rahel BM; Laarman GJ; Slagboom T; Kelder JC; Ten Berg JM; Suttorp MJ EuroIntervention; 2012 Feb; 7(10):1189-96. PubMed ID: 22030323 [TBL] [Abstract][Full Text] [Related]
34. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME; N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301 [TBL] [Abstract][Full Text] [Related]
35. Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. Stone GW; Lansky AJ; Pocock SJ; Gersh BJ; Dangas G; Wong SC; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Möckel M; Ochala A; Kellock A; Parise H; Mehran R; N Engl J Med; 2009 May; 360(19):1946-59. PubMed ID: 19420364 [TBL] [Abstract][Full Text] [Related]
36. Drug-eluting stents during ST-segment elevation acute myocardial infarction: a critical analysis. Andrade PB; Tebet MA; Silva FS; Andrade MV; Labrunie A; Piva e Mattos LA J Interv Cardiol; 2011 Oct; 24(5):416-23. PubMed ID: 21539610 [TBL] [Abstract][Full Text] [Related]
37. Everolimus-eluting versus paclitaxel-eluting stents for treatment of bare metal stent restenosis. Almalla M; Schröder JW; Pross V; Stegemann E; Marx N; Hoffmann R Am J Cardiol; 2011 Aug; 108(4):518-22. PubMed ID: 21624553 [TBL] [Abstract][Full Text] [Related]
38. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods. Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737 [TBL] [Abstract][Full Text] [Related]
39. Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy. Campo G; Punzetti S; Malagù M; Ferrari R; Valgimigli M Int J Cardiol; 2014 May; 173(2):343-5. PubMed ID: 24680246 [No Abstract] [Full Text] [Related]
40. [Acute coronary syndrome is a common clinical manifestation of in-stent restenosis]. Zhang YZ; Mao JM; Guo LJ; Zhang FC; Niu J; Li HY Zhonghua Nei Ke Za Zhi; 2003 Jul; 42(7):470-2. PubMed ID: 12921605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]